PURPOSE: The family of cathepsin proteases plays an important physiological role in both normal physiology and in the physiology of many human diseases. This activity, which is upregulated in many cancers, can be exploited for tumor imaging both in vivo and ex vivo. To characterize the behavior of a topically applied quenched fluorescent activity-based probe, GB119, ex vivo, we developed a basic immunohistochemistry technique to identify unquenched GB119 within tissue. PROCEDURES: Immunoblot assays were used to validate the utility of an anit-Cy5 antibody for the detection of unquenched GB119 generated by cathepsin-L. Following validation of the anti-Cy5 antibody, an immunohistochemical procedure was developed to detect the presence of unquenched GB119 in frozen sections of brain tumors derived from an orthotopic mouse model. RESULTS: These studies demonstrate that the anti-Cy5 antibody preferentially recognizes unquenched GB119 and that this differential can be used to identify the regions within the brain and the tumor that contained unquenched GB119. Using H&E staining and antibodies against other biochemical markers, it was further determined that unquenched GB119 was localized to the peri-tumor space and co-localized with cathepsin-L expression. CONCLUSION: Our data indicate that this methodology allows high-resolution detection of unquenched GB119 that can be correlated with other immunohistological stains.
PURPOSE: The family of cathepsin proteases plays an important physiological role in both normal physiology and in the physiology of many human diseases. This activity, which is upregulated in many cancers, can be exploited for tumor imaging both in vivo and ex vivo. To characterize the behavior of a topically applied quenched fluorescent activity-based probe, GB119, ex vivo, we developed a basic immunohistochemistry technique to identify unquenched GB119 within tissue. PROCEDURES: Immunoblot assays were used to validate the utility of an anit-Cy5 antibody for the detection of unquenched GB119 generated by cathepsin-L. Following validation of the anti-Cy5 antibody, an immunohistochemical procedure was developed to detect the presence of unquenched GB119 in frozen sections of brain tumors derived from an orthotopic mouse model. RESULTS: These studies demonstrate that the anti-Cy5 antibody preferentially recognizes unquenched GB119 and that this differential can be used to identify the regions within the brain and the tumor that contained unquenched GB119. Using H&E staining and antibodies against other biochemical markers, it was further determined that unquenched GB119 was localized to the peri-tumor space and co-localized with cathepsin-L expression. CONCLUSION: Our data indicate that this methodology allows high-resolution detection of unquenched GB119 that can be correlated with other immunohistological stains.
Authors: Galia Blum; Stefanie R Mullins; Kinneret Keren; Marko Fonovic; Christopher Jedeszko; Mark J Rice; Bonnie F Sloane; Matthew Bogyo Journal: Nat Chem Biol Date: 2005-08-14 Impact factor: 15.040
Authors: Galia Blum; Georges von Degenfeld; Milton J Merchant; Helen M Blau; Matthew Bogyo Journal: Nat Chem Biol Date: 2007-09-09 Impact factor: 15.040
Authors: Jennifer M Rothberg; Kate M Bailey; Jonathan W Wojtkowiak; Yael Ben-Nun; Matthew Bogyo; Ekkehard Weber; Kamiar Moin; Galia Blum; Raymond R Mattingly; Robert J Gillies; Bonnie F Sloane Journal: Neoplasia Date: 2013-10 Impact factor: 5.715
Authors: Tatsuya Abe; Hiroaki Wakimoto; Robert Bookstein; Daniel C Maneval; E Antonio Chiocca; James P Basilion Journal: Cancer Gene Ther Date: 2002-03 Impact factor: 5.987
Authors: S A Rempel; M L Rosenblum; T Mikkelsen; P S Yan; K D Ellis; W A Golembieski; M Sameni; J Rozhin; G Ziegler; B F Sloane Journal: Cancer Res Date: 1994-12-01 Impact factor: 12.701
Authors: Ethan Walker; Yiqiao Liu; InYoung Kim; David L Wilson; James P Basilion; Daniel L Popkin; Mark Biro; Sukanya Raj Iyer; Harib Ezaldein; Jeffrey Scott; Miesha Merati; Rachel Mistur; Bo Zhou; Brian Straight; Joshua J Yim; Matthew Bogyo; Margaret Mann Journal: Cancer Res Date: 2020-03-04 Impact factor: 12.701
Authors: Ethan Walker; Margaret Mann; Kord Honda; Allison Vidimos; Mark D Schluchter; Brian Straight; Matthew Bogyo; Daniel Popkin; James P Basilion Journal: J Am Acad Dermatol Date: 2016-11-19 Impact factor: 11.527
Authors: Yiqiao Liu; Ethan Walker; Sukanya Raj Iyer; Mark Biro; InYoung Kim; Bo Zhou; Brian Straight; Matthew Bogyo; James P Basilion; Daniel L Popkin; David L Wilson Journal: J Med Imaging (Bellingham) Date: 2019-03-18
Authors: Ethan Walker; Daan G J Linders; Eric Abenojar; Xinning Wang; Hans Marten Hazelbag; Marieke E Straver; Okker D Bijlstra; Taryn L March; Alexander L Vahrmeijer; Agata Exner; Matthew Bogyo; James P Basilion; Brian Straight Journal: Cancers (Basel) Date: 2022-07-16 Impact factor: 6.575